Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s

In conclusion, this study demonstrates that baicalein ameliorates colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s, thus providing a potential therapy for UC.PMID:34671110 | DOI:10.1038/s41401-021-00781-7

Source: Acta Pharmacologica Sinica - October 21, 2021 Category: Drugs & Pharmacology Authors: Yan-Yang Li Xiao-Jing Wang Yu-Lin Su Qing Wang Shao-Wei Huang Zeng-Feng Pan Yan-Ping Chen Jun-Jie Liang Mei-Ling Zhang Xue-Qian Xie Zhi-Yun Wu Jin-Yan Chen Lian Zhou Xia Luo Source Type: research